New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)

Type 1 Diabetes ◽

Insulin Glargine ◽

Glucose Control ◽

Controlled Trial ◽

Randomized Controlled ◽

Japanese Adults ◽

Mealtime Insulin

A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes

PEDIATRICS ◽

10.1542/peds.2007-1679 ◽

2008 ◽

Vol 121 (3) ◽

pp. e466-e472 ◽

Cited By ~ 23

Author(s):

K. Hassan ◽

L. M. Rodriguez ◽

S. E. Johnson ◽

S. Tadlock ◽

R. A. Heptulla

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Newly Diagnosed ◽

Insulin Analogs ◽

Randomized Controlled ◽

Acting Insulin ◽

Neutral Protamine Hagedorn

Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial

Diabetes Technology & Therapeutics ◽

10.1089/dia.2017.0353 ◽

2018 ◽

Vol 20 (3) ◽

pp. 189-196 ◽

Cited By ~ 13

Author(s):

Alexander Abitbol ◽

Remi Rabasa-Lhoret ◽

Virginie Messier ◽

Laurent Legault ◽

Mohamad Smaoui ◽

...

Keyword(s):

Type 1 Diabetes ◽

Glucose Control ◽

Controlled Trial ◽

Artificial Pancreas ◽

Hypoglycemia Unawareness ◽

Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc20-0112 ◽

2020 ◽

Vol 43 (11) ◽

pp. 2744-2750

Author(s):

Aneta Hásková ◽

Lucie Radovnická ◽

Lenka Petruželková ◽

Christopher G. Parkin ◽

George Grunberger ◽

...

Keyword(s):

Type 1 Diabetes ◽

Real Time ◽

Glucose Control ◽

Controlled Trial ◽

Glucose Monitoring ◽

Flash Glucose Monitoring ◽

Comment on Hásková et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744–2750

Diabetes Care ◽

10.2337/dc20-2905 ◽

2021 ◽

Vol 44 (4) ◽

pp. e75-e76

Author(s):

Alexander Seibold

Keyword(s):

Type 1 Diabetes ◽

Real Time ◽

Diabetes Care ◽

Glucose Control ◽

Controlled Trial ◽

Glucose Monitoring ◽

Flash Glucose Monitoring ◽

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Diabetes Care ◽

10.2337/dc14-0991 ◽

2014 ◽

Vol 37 (10) ◽

pp. 2755-2762 ◽

Cited By ~ 188

Author(s):

Matthew C. Riddle ◽

Geremia B. Bolli ◽

Monika Ziemen ◽

Isabel Muehlen-Bartmer ◽

Florence Bizet ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Glucose Control ◽

Controlled Trial ◽

Randomized Controlled ◽

Mealtime Insulin

Response to Comment on Hásková et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care 2020;43:2744–2750

Diabetes Care ◽

10.2337/dci20-0078 ◽

2021 ◽

Vol 44 (4) ◽

pp. e77-e78

Author(s):

Jan Šoupal ◽

Aneta Hásková ◽

Martin Prázný

Keyword(s):

Type 1 Diabetes ◽

Real Time ◽

Diabetes Care ◽

Glucose Control ◽

Controlled Trial ◽

Glucose Monitoring ◽

Flash Glucose Monitoring ◽

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Diabetes Care ◽

10.2337/dc10-1925 ◽

2011 ◽

Vol 34 (3) ◽

pp. 661-665 ◽

Cited By ~ 121

Author(s):

K. I. Birkeland ◽

P. D. Home ◽

U. Wendisch ◽

R. E. Ratner ◽

T. Johansen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Insulin Degludec ◽

Randomized Controlled ◽

Acting Insulin ◽

Long Acting ◽

New Generation

Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring

Diabetes Obesity and Metabolism ◽

10.1111/dom.13751 ◽

2019 ◽

Vol 21 (8) ◽

pp. 1906-1913 ◽

Cited By ~ 3

Author(s):

Jeremy Pettus ◽

Jasvinder Gill ◽

Sachin Paranjape ◽

John Stewart ◽

Shilpy Malla ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Controlled Trial ◽

Glucose Monitoring ◽

Adult Patients ◽

Efficacy And Safety ◽

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc19-1926 ◽

2020 ◽

Vol 43 (7) ◽

pp. 1512-1519 ◽

Cited By ~ 3

Author(s):

Thomas Danne ◽

William V. Tamborlane ◽

Oleg A. Malievsky ◽

Denise R. Franco ◽

Tomoyuki Kawamura ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Children And Adolescents ◽

Controlled Trial ◽

Efficacy And Safety ◽

Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: a phase III , randomized, controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14463 ◽

2021 ◽

Author(s):

Xiang Yan ◽

Shan Jiang ◽

Ying Lou ◽

Zhiguang Zhou

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Phase Iii ◽

Chinese Patients ◽

Comparable Efficacy ◽

Efficacy And Safety ◽